OBIO icon

Orchestra BioMed
OBIO

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$13.67
188% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Chardan Capital
Chardan Capital
Keay Nakae
50% 1-yr OBIO win rate
13 Nov ‘25 20 days ago
Barclays
Barclays
Matt Miksic
67% 1-yr OBIO win rate
12 Nov ‘25 21 days ago
HC Wainwright & Co
HC Wainwright & Co
Yi Chen
33% 1-yr OBIO win rate
4 Sep ‘25 3 months ago